News
Late-breaker at EADV shows once-daily pill beats placebo, giving skincare writers acne drug pipeline keywords and full poster PDF.
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studiesIcotrokinra also showed ...
HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback